The transcription factor ChREBP links mitochondrial lipidomes to mitochondrial morphology and progression of diabetic kidney disease

Li Li, Jianyin Long, Koki Mise, Naravat Poungavrin, Philip L. Lorenzi, Iqbal Mahmud, Lin Tan, Pradip K. Saha, Yashpal S. Kanwar, Benny H. Chang, Farhad R. Danesh*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

A substantial body of evidence has established the contributions of both mitochondrial dynamics and lipid metabolism to the pathogenesis of diabetic kidney disease (DKD). However, the precise interplay between these two key metabolic regulators of DKD is not fully understood. Here, we uncover a link between mitochondrial dynamics and lipid metabolism by investigating the role of carbohydrate-response element-binding protein (ChREBP), a glucose-responsive transcription factor and a master regulator of lipogenesis, in kidney podocytes. We find that inducible podocyte-specific knockdown of ChREBP in diabetic db/db mice improves key biochemical and histological features of DKD in addition to significantly reducing mitochondrial fragmentation. Because of the critical role of ChREBP in lipid metabolism, we interrogated whether and how mitochondrial lipidomes play a role in ChREBP-mediated mitochondrial fission. Our findings suggest a key role for a family of ether phospholipids in ChREBP-induced mitochondrial remodeling. We find that overexpression of glyceronephosphate O-acyltransferase, a critical enzyme in the biosynthesis of plasmalogens, reverses the protective phenotype of ChREBP deficiency on mitochondrial fragmentation. Finally, our data also points to Gnpat as a direct transcriptional target of ChREBP. Taken together, our results uncover a distinct mitochondrial lipid signature as the link between ChREBP-induced mitochondrial dynamics and progression of DKD.

Original languageEnglish (US)
Article number105185
JournalJournal of Biological Chemistry
Volume299
Issue number9
DOIs
StatePublished - Sep 2023

Funding

We thank all members of the Danesh laboratory for their helpful discussions. We acknowledge the High Resolution Electron Microscopy Facility at MD Anderson Cancer Center (CCSG NIH P30CA016672) for helping with TEM experiments; the Metabolic Core Facility at MD Anderson Cancer Center ( Cancer Prevention and Research Institute of Texas grant RP130397 , NIH grants S10OD012304-01 and P30CA016672 ) for performing lipidomic studies; the Flow Cytometry and Cellular Imaging Core Facility at MD Anderson Cancer Center( NCI grant P30CA16672 ) for advice and help in flow cytometry experiments. This work was supported by National Institutes of Health grants R01DK078900 and R01DK091310 (to F. R. D.). L. L. is supported by a scholarship from the China Scholarship Council (202006370196). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Keywords

  • diabetic nephropathy
  • kidney metabolism
  • lipid metabolism
  • mitochondria
  • phospholipid

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'The transcription factor ChREBP links mitochondrial lipidomes to mitochondrial morphology and progression of diabetic kidney disease'. Together they form a unique fingerprint.

Cite this